FAST-2020-R-0014
Federal and State Technology (FAST) Partnership Program to Provide Organizations with Funding for Outreach, Mentoring, Technical and Business Assistance to R&D-focused Small Businesses Interested in the SBIR/STTR Federal R&D Programs. The U.S. Small Business Administration (SBA) plans to issue Notice of Funding Opportunity No. SBA-OIIFT-20-001 with estimated total program funding of $3,000,000. The award ceiling is $125,000 and the award floor is $0. Applicants may request any amount up to the award ceiling. Funding will go to organizations to conduct proposal development training, outreach, mentoring, financial support, technical and business assistance to R&D focused small businesses interested in the SBIR/STTR Programs. Applications will be considered from all 50 states, U.S. territories and the District of Columbia. This program is authorized by Public Law (P.L.) 116-93 and 15 U.S.C. 657d(c). Only one proposal from each state may be submitted to the SBA for consideration and this application must have a signed letter of endorsement from the state governor or equivalent.

Funding Agency: Small Business Administration
Deadline: June 19, 2020
Amount: $125,000
For more information: https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=73403

Preventing Adverse Childhood Experiences Data to Action
Centers for Disease Control and Prevention (CDC) announces a notice of funding opportunity (NOFO) for Preventing Adverse Childhood Experiences: Data to Action (PACE:D2A), a cooperative agreement designed to address state-specific needs related to the prevention of adverse childhood experiences (ACEs). The two primary goals of this NOFO are 1) to build a state-level surveillance infrastructure that ensures the capacity to collect, analyze, and use ACE data to inform statewide ACE prevention activities; and 2) to support the implementation of data-driven, comprehensive, evidence-based ACE primary prevention strategies; and provide technical support to states in these efforts. This NOFO has three required foci to support these goals – 1) enhance or build the infrastructure for the state-level collection, analysis, and application of ACE-related surveillance data that can be used to inform and tailor ACE prevention activities, 2) implement strategies based on the best available evidence to prevent ACEs, and 3) conduct data to action activities to continue to assess state-wide surveillance and primary prevention needs and make needed modifications. The work of these foci, and the infrastructure and expertise exerted to accomplish that work, should be interdependent and should be planned and implemented as part of a comprehensive and coordinated ACE prevention dynamic system that reflects the 10 Essential Public Health Services promoted by CDC.

Funding Agency: Centers for Disease Control – NCIPC
Deadline: July 13, 2020
Amount: $500,000
For more information: Go to grants.gov and search opportunity #CDC-RFA-CE20-2006

Substance Use/Substance Use Disorder Dissertation Research Award (R36 – Clinical Trials Optional)
The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (https://www.drugabuse.gov/funding/funding-priorities) or within the NIDA Strategic Plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers. Applications are particularly encouraged from those who can contribute to diversifying the research workforce as described in the Notice of NIH’s Interest in Diversity (NOT-OD-20-031).

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-208.html

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-207.html

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-204.html

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-205.html

Nexus Start-Up Hub 2.0
Background: There is a strong desire across business sectors in India to study and adapt the skills and values of the American entrepreneurial ecosystem. With the goal of building cultural and economic bridges between individuals and companies in the start-up space, Nexus Start-up Hub at the American Center New Delhi opened in Spring 2017. Nexus quickly established itself as a leader in sharing American best practices with Indian entrepreneurs – male and female – from across India. The Public Affairs Section in New Delhi plans to continue providing this expertise, preparing these future business leaders to engage with Indo-Pacific investors and business partners, especially those from the United States, while also broadening the scope of Nexus to reach a larger, more diverse audience. Nexus annually recruits and trains three cohorts of 10 to 15 start-up companies per 10-week residential session. To date, the Nexus Start-up Hub at the American Center New Delhi has produced 97 companies or “graduates” in its alumni network. Nexus graduates have raised more than $6 million in funding. In addition to creating more than 1,000 new jobs, Nexus graduates have generated more than $4.7 million in revenue. They have also concluded 28 deals with U.S. companies. In 2019, Nexus led short, 2.5-day entrepreneurship training workshops in four other cities across India. Also in 2019, Nexus conducted a targeted 2-day entrepreneurship workshop in Hyderabad for startups working in the defense/military sector, in conjunction with a business/government leaders’ conference highlighting U.S.-India cooperation in the defense sector. India currently hosts more than 400 incubators across the country. Indian entrepreneurs are hungry for the guidance, strategic support, and skill-building that incubators may offer. As a result of some initial engagement with incubator managers in 2019, we have observed greater interest and opportunity to engage more broadly with incubator managers across India. There is great scope to engage with this community by providing knowledge and training in state-of-the-art American incubator management and utilizing this platform to extend the reach of American entrepreneurship expertise.

Proposed Project: To implement a full-time, India-wide residential incubator hub at the American Center New Delhi; organize regional entrepreneurship workshops across India in critical economic sectors such as health/pharmaceuticals/biotechnology, defense/military, agriculture, and higher education; and develop a series of training seminars for incubator managers across India. This project has a target start date of January 1, 2021.

Funding Agency: U.S. Mission to India
Deadline: July 31, 2020
Amount: $1,000,000
For more information: Go to grants.gov and search opportunity # ND-NOFO-20-113

Research Program Award (R35 Clinical Trial Optional)
Reissue of RFA-NS-18-032. The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors (PDs) /Principal Investigators (PIs) whose records of research achievement demonstrate their ability to make major contributions to neuroscience. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PI’s recent NINDS support (Part 2, Section II) This greater funding stability will provide eligible investigators at nearly all career stages increased freedom and flexibility, allowing them to be more adventurous in their research, take greater risks, embark upon research that breaks new ground, undertake research projects that require a longer timeframe, and/or extend previous discoveries in new directions. Research supported through the RPA must be within the scope of the NINDS mission (http://www.ninds.nih.gov/about_ninds/mission.htm). Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center will not be considered through this program. Other anticipated benefits of the RPA include: A more stable funding environment, facilitating the pursuit of longer-term research goals; Flexible funding, enabling investigators to pursue research opportunities as they arise, not tied to specific aims; Reduced time spent writing grant applications and managing multiple grant awards, thereby allowing investigators to spend more time conducting and overseeing research; and More time for PDs/PIsto mentor junior scientists. Eligibility to apply through this FOA is limited to investigators who currently have at least one active NINDS R01 or R01 equivalent grant (defined here as R00, R01, R37, R56, DP1 or DP2 awards), and who have had an active R01 equivalent grant from NINDS in each of the past 5 years, with no more than one of those years in a no cost extension.

Funding Agency: National Institutes of Health
Deadline: July 31, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-030.html

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-203.html

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
To support generation of single cell RNA-sequencing data sets for at least one brain region relevant to persistent HIV infection and opioid, cocaine and/or methamphetamine use disorder

Funding Agency: National Institutes of Health
Deadline: July 20, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-019.html

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-201.html

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-202.html

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-206.html

Metastasis Research Network (U54 Clinical Trial Not Allowed)
The purpose of the FOA is to support the development of collaborative, multi-disciplinary basic research centers to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. It is anticipated that each center will use systems-level approaches that encompass chronological progression and biological scales to derive a more comprehensive and cohesive picture of metastasis. Centers may derive new physiologically relevant models that capture the entire metastatic process or develop new experimental and analytical technologies or probes for tracking and monitoring the in vivo dynamics of metastatic cell states.

Funding Agency: National Institutes of Health
Deadline: May 28, 2021
Amount: $1,200,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-029.html

Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-151.html

HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)
The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding Agency: National Institutes of Health
Deadline: May 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PA-20-149.html

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)
This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic. AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19. AHRQ encourages multi-method, rapid-cycle research with the ability to: produce and disseminate initial findings (e.g. observations, lessons learned, or findings) within 6 months after award and then regularly throughout the remainder of the award period.

Funding Agency: Agency for Health Care Research and Quality
Deadline: June 15, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-20-003.html

Advanced Reactor Demonstration
This program is intended to facilitate the development of U.S. private industry advanced nuclear reactor demonstrations. It will provide funding for several advanced reactors that are reliable, cost effective, licensable, and commercially viable. These designs are expected to enable a market environment in which commercial reactor services are available that are safe and affordable to both construct and operate when compared to competing, alternative sources of energy in the near- and mid-term. These designs are expected to provide significant improvements in safety, security, economics, and environmental impacts over current nuclear power plant designs. As a part of its mission, the United States (U.S.) Department of Energy (DOE), Office of Nuclear Energy (NE) has a long and successful history of working with the domestic nuclear industry, national laboratories, and academia to support the development of advanced reactor designs and capabilities over a continuum of technology maturity levels. DOE currently supports research and development (R&D) activities for a variety of advanced reactor technologies that are expected to improve on the safety, security, economics, and/or environmental impacts of current nuclear power plant designs. DOE undertakes these activities in support of the Administration’s objectives to maintain the Nation’s technological leadership position in the global nuclear industry and ensure national energy security. DOE recognizes that work remains to ensure continued U.S. leadership in the research, design, and development of advanced reactors and to ensure the successful deployment of these reactors in the U.S. and international marketplaces. As part of the FY2020 Further Consolidation Appropriations Act, (H.R. 1865), Congress has provided funding for NE to address advanced reactor development at various stages of the technology maturity continuum. This Funding Opportunity Announcement (FOA) is comprised of three separate pathways. The Advanced Reactor Demonstration Program (ARDP) has a goal of focusing DOE and non-federal resources (through cost shared agreements with industry) on the actual construction of real demonstration reactors that are safe and affordable to build in the near- to mid-term. ARDP identifies two separate pathways to meet this goal: 1) Advanced Reactor Demonstrations, which supports two reactor designs to be operational in 5-7 years; and, 2) Risk Reduction for Future Demonstration awards which supports 2-5 additional diverse advanced reactor designs that have a commercialization horizon that is approximately 5 years longer than the Advanced Reactor Demonstrations. A third path, identified in H.R. 1865, Advanced Reactor Concepts – 20, will support development of at least two new public-private partnership awards focused on advancing reactor designs toward the demonstration phase; these have a commercialization horizon that is approximately 5 years longer than the Risk Reduction for Future Demonstration awards.

Funding Agency: Idaho Field Office
Deadline: August 12, 2020
Amount: $4,000,000
For more information: https://www.id.energy.gov/

NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage.

Funding Agency: National Institutes of Health
Deadline: January 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-209.html

NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage.

Funding Agency: National Institutes of Health
Deadline: January 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-210.html

Gender-Based Violence Prevention for Ecuador’s Education System
The United States Department of State’s Bureau of Western Hemisphere Affairs (WHA) announces a Notice of Funding Opportunity (NOFO) to support a gender-based violence prevention (GBV) project focused on GBV in Ecuador’s education system. Subject to availability of funds, WHA intends to issue one award of up to $641,975 in FY 2019 Economic Support Funds for a project period of up to two (2) years. The anticipated start date for this activity is September 2020. Grant funds cannot directly assist or support GBV survivors; rather grant funds should support the government of Ecuador and civil society to improve access to services and response to sexual violence and harassment in society, particularly in the educational system. The $641,975 is attributed to a global U.S. Department of State congressional GBV earmark, and supports the U.S. Department of State and the Administration’s Women Peace and Security (WPS) Policy Outcomes 2 and 3 and the Women’s Global Development and Prosperity(W-GDP) Initiative Pillar 3.

Funding Agency: Bureau of Western Hemisphere Affairs
Deadline: June 30, 2020
Amount: $641,975
For more information: Go to grants.gov and search opportunity #SFOP0006943

Social Science Research Council Issues Call for Proposals for Social Science and COVID-19 Research
In partnership with the Henry Luce Foundation, the Social Science Research Council (SSRC) is requesting proposals from across the social sciences that address the social, economic, cultural, psychological, and political impact of COVID-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects. Through the council’s COVID-19 Rapid-Response Grants program, innovative research projects that deploy remote research methods to shed light on both the short- and potential long-term effects of COVID-19 across a range of issues will be supported, including “social distancing” and virtual social interaction; governance and democracy; public trust and (dis)information; social inequality and the pandemic’s disproportionate effects by race and ethnicity; the lessons of past disasters, and responses to them, for the present; the role of religious ideas, practices, and institutions in responding to the pandemic; the workplace and labor markets; technology, surveillance, and ethics; and the uses of, and the limits to, modeling in responses to the pandemic’s effects and in scenario planning. Awards will range from $2,000 to $5,000 for projects over six months, with the possibility of slightly more support for collaborative projects of two or more researchers. To be eligible, applicants must hold a PhD in any social science disciplines or related interdisciplinary fields. See the Social Science Research Council website for complete program guidelines and application instructions.

Funding Agency: Social Science Research Council
Deadline: June 1, 2020
Amount: $5,000
For more information: https://covid19research.ssrc.org/rapid-response-grants-on-covid-19-and-the-social-sciences/